FDC has received approval for buyback of its own fully paid up equity shares of Re 1 each equity shares from the equity shareholders of the Company, not exceeding 34,30,000 fully paid up Equity Shares at a price of Rs 350 per equity share for an aggregate amount not exceeding Rs 120.05 crore being less than 10% of the Paid Up Capital and free reserves as on March 31, 2019 from the existing equity shareholders of the Company. The Board of Directors of the Company at its meeting held on May 24, 2019 has approved the same.
FDC is engaged in manufacture of specialized formulations, and oral rehydration salts (ORS).
